The impact of long-term conventional treatment for overlap syndrome (obstructive sleep apnea and chronic obstructive pulmonary disease) on concurrent erectile dysfunction

Respiratory Medicine

Volumn 101, Issue 2, 2007, Pages 210-216

  Perimenis, Petros ^a   Karkoulias, Kyriakos ^b   Konstantinopoulos, Agelis ^a   Alchanatis, Manos ^b   Perimeni, Paraskevi P ^b   Athanasopoulos, Anastasios ^a   Spyropoulos, Konstantinos ^b  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Bronchodilators; COPD; CPAP; Erectile dysfunction; Obstructive sleep apnea; Overlap syndrome; QoL

Indexed keywords

BRONCHODILATING AGENT; FORMOTEROL; SALMETEROL; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ADULT; AGE; AGED; APNEA; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; ERECTILE DYSFUNCTION; HUMAN; LONG TERM CARE; MALE; OXYGEN SATURATION; PATIENT SATISFACTION; PENIS ERECTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SCORING SYSTEM; SLEEP APNEA SYNDROME; TREATMENT OUTCOME;

AGE FACTORS; BODY MASS INDEX; BRONCHODILATOR AGENTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; OXYGEN; PATIENT SATISFACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SLEEP APNEA, OBSTRUCTIVE; SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 33846162776     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.06.012     Document Type: Article

References (34)

1. Malhotra A., and White D.P. Obstructive sleep apnea. Lancet 360 (2002) 237-245
2. Bradley D.T., and Floras J.S. Sleep apnea and heart failure. Part 1: obstructive sleep apnea. Circulation 107 (2003) 1671-1678
3. Fanfulla F., Malaguti S., Montagna T., et al. Erectile dysfunction in men with obstructive sleep apnea: an early sign of nerve involvement. Sleep 23 (2000) 775-781
4. Hirshkowitz M., Karacan I., Gurakar A., and Williams R.I. Hypertension, erectile dysfunction, and occult sleep apnea. Sleep 12 (1989) 223-232
5. Pressman M.R., DiPhillipo M.A., Kendrick J.I., Conroy K., and Fry J.M. Problems in the interpretation of nocturnal penile tumescence studies: disruption of sleep by occult sleep disorders. J Urol 136 (1986) 595-598
6. Ibanez M., Aguilar J.J., Maderal M.A., et al. Sexuality in chronic respiratory failure: coincidences and divergences between patient and primary caregiver. Respir Med 95 (2001) 975-979
7. Alexandre B., Lemaire A., Roche N., Huchon G., and Buvat J. Respiratory disease and sexual dysfunction: a national survey among patients associations. J Sex Med Suppl 1 (2004) 112
8. Flenley D.C. Sleep in chronic obstructive lung disease. Clin Chest Med 6 (1985) 651-661
9. Young T., Palta M., Dempsey J., Skaturd J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (1993) 1230-1235
10. Sanders M.H., Newman A.B., Haggerty C.L., et al. Sleep and sleeep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Crit Care Med 167 (2003) 7-14
11. Hirshkowitz M., Karacan I., Arcasoy M.O., Acik G., Narter E.M., and Williams R.L. Prevalence of sleep apnea in men with erectile dysfunction. Urology 36 (1990) 232-234
12. Siafakas N.M., Vermeire P., Pride N.B., Paoletti P., Gibson J., Howard P., et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 8 8 (1995) 1398-1420
13. American Sleep Association. The international classifications of sleep disorders, revised: diagnostic and coding manual. Rochester, MN: Davies; 1997. p. 1-401.
14. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22 (1999) 667-689
15. Guideline for the Management of Chronic Obstructive Pulmonary Disease (COPD), 2004. Revision. S Afr Med J 2004;94:559-75.
16. Committee 4Symptom score and quality of life. In: Jardin A., Wagner G., Khoury S., Giuliano F., Padma- Nathan H., and Rosen R. (Eds). First International Consensus on Erectile Dysfunction (2000), Health Publications Ltd, Plymouth 103-114
17. Haight J.S., and Djupesland P.G. Nitric oxide (NO) and obstructive sleep apnea (OSA). Sleep Breath 7 (2003) 53-61
18. Massberg S., Sausbier M., Klatt P., et al. Increased adhesion and aggregation of platelets lacking cyclic guanosine 3′ -5′-monophosphate kinase. I. J Exp Med 189 (1999) 1255-1263
19. Bolli R. Cardioprotective function of inducible nitric oxide synthesis and role of nitric oxide in myocardial ischaemia and preconditioning: an overview of a decade research. J Mol Cell Cardiol 33 (2001) 1897-1918
20. Lewis R.D., Hatzichristou D.G., Laumann E., and McKinlay J.B. Epidemiology and natural history of erectile dysfunction: risk factors including iatrogenic and ageing. In: Jardin A., Wagner G., Khoury S., Giuliano F., Goldstein I., and Padma-Nathan H. (Eds). Recommendations of the First International Consultation on Erectile Dysfunction, cosponsored by the World Health Organization (WHO) (2000), Health Publication Ltd, Plymouth 21-51
21. Perimenis P., Karkoulias K., Markou S., et al. Erectile dysfunction in men with obstructive sleep apnea syndrome: a randomized study of the efficacy of sildenafil and continuous positive airway pressure. Int J Impot Res 16 (2004) 256-260
22. Li F., Feng Q., Zhang X., and Liu Q. Treatment of erectile dysfunction in patients with obstructive sleep apnea syndrome by nasal continual positive airway pressure. Zhonghua Nan Ke Xue 10 (2004) 355-357
23. Margel D., Tal R., Livne P.M., and Pillar G. Prediction of erectile function improvement in obstructive sleep apnea with long-term CPAP treatment. Int J Impot Res 17 (2005) 186-190
24. Campos M.A., and Wanner A. The rationale for pharmacologic therapy in stable chronic obstructive pulmonary disease. Am J Med Sci 329 (2005) 181-189
25. Aasebo U., Gyltnes A., Bremnes R.M., Aakvaag A., and Slordal L. Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long-term oxygen therapy. J Steroid Biochem Mol Biol 46 (1993) 799-803
26. Walbroehl G.S. Sexual concerns of the patient with pulmonary disease. Postgrad Med 9 (1992) 455-460
27. Kourembanas S., Marsden P.A., McQuillan L.P., and Faller D.V. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 88 (1991) 1054-1057
28. Phillips B., Narkiewicz K., Pesek C.A., Haynes W.G., Dyken M.E., and Somers V.K. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17 (1999) 61-66
29. Schulz R., Schimidt D., Blum A., et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 55 (2000) 1046-1051
30. Ip M.S.M., Lam B., Chan L., et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162 (2000) 2166-2171
31. Teramoto S., Kume H., Matsuse T., et al. Oxygen administration improves the serum level of nitric oxide metabolites in patients with obstructive sleep apnea syndrome. Sleep Med 4 (2003) 403-407
32. Barnes P.J. The pharmacological properties of tiotropium. Chest 117 (2000) 63S-66S
33. Cazzola M., and Donner C.F. Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease. Drugs 60 (2000) 307-320
34. Spina D. Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease. Drugs 63 (2003) 2575-2594